Evaluative updates on donor organ usage and therapeutic interventions for pediatric kidney transplantation, suggesting new care standards.
Transplant teams should consider using a broader range of donor organs in select pediatric patients. Further interventional research on peritransplant thromboprophylaxis and fluid management is needed to optimize management strategies. The completion of ongoing belatacept and letermovir trials have the potential to substantially alter posttransplant standards of care.
No takes yet. Share an insight, caveat, or question.
Rachel M. Engen (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: